π
|
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma.
24 auth.
I. Ben-Batalla,
A. Schultze,
M. Wroblewski,
R. Erdmann,
M. Heuser,
J. Waizenegger,
K. Riecken,
M. Binder,
D. Schewe,
S. Sawall,
...
V. Witzke,
M. Cubas-Cordova,
M. Janning,
J. Wellbrock,
B. Fehse,
C. Hagel,
J. Krauter,
A. Ganser,
J. Lorens,
W. Fiedler,
P. Carmeliet,
K. Pantel,
C. Bokemeyer,
S. Loges
|
7 |
2013 |
7 π
|
π
|
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy.
17 auth.
R. Bauer,
F. Udonta,
M. Wroblewski,
I. Ben-Batalla,
InΓͺs Vasconcelos Miranda Santos,
Federico Taverna,
M. Kuhlencord,
Victoria Gensch,
Sarina Paesler,
S. Vinckier,
...
J. Brandner,
K. Pantel,
C. Bokemeyer,
T. Vogl,
J. Roth,
P. Carmeliet,
S. Loges
|
6 |
2018 |
6 π
|
π¦
|
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B
14 auth.
M. Wroblewski,
R. Bauer,
M. C. CΓ³rdova,
F. Udonta,
I. Ben-Batalla,
K. Legler,
C. L. HΓ€user,
J. Egberts,
M. Janning,
J. Velthaus,
...
Christian Schulze,
Klaus Pantel,
Carsten Bokemeyer,
S. Loges
|
6 |
2017 |
6 π¦
|
π
|
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
25 auth.
J. Waizenegger,
I. Ben-Batalla,
N. Weinhold,
T. Meissner,
M. Wroblewski,
M. Janning,
K. Riecken,
R. Binder,
D. Atanackovic,
H. Taipaleenmaeki,
D. Schewe,
S. Sawall,
Victoria Gensch,
M. Cubas-Cordova,
A. Seckinger,
...
W. Fiedler,
E. Hesse,
N. KrΓΆger,
B. Fehse,
D. Hose,
B. Klein,
M. Raab,
K. Pantel,
C. Bokemeyer,
S. Loges
|
5 |
2014 |
5 π
|
π¬
|
Acute Myelogenous Leukemia and its Microenvironment: A Molecular Conversation.
G. Ghiaur,
M. Wroblewski,
S. Loges
|
4 |
2015 |
4 π¬
|
π
|
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs
15 auth.
I. Ben-Batalla,
M. Cubas-Cordova,
F. Udonta,
M. Wroblewski,
J. Waizenegger,
M. Janning,
S. Sawall,
Victoria Gensch,
Lin Zhao,
I. Martinez-Zubiaurre,
...
K. Riecken,
B. Fehse,
K. Pantel,
C. Bokemeyer,
S. Loges
|
4 |
2015 |
4 π
|
π
|
A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition
14 auth.
Lars Schiffmann,
M. Brunold,
M. Liwschitz,
V. Goede,
S. Loges,
M. Wroblewski,
A. Quaas,
Hakan Alakus,
D. Stippel,
C. Bruns,
...
M. Hallek,
H. Kashkar,
U. Hacker,
O. Coutelle
|
4 |
2017 |
4 π
|
π¦
|
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells
21 auth.
M. Wroblewski,
M. Scheller-Wendorff,
F. Udonta,
R. Bauer,
J. Schlichting,
Lin Zhao,
Isabel Ben Batalla,
Victoria Gensch,
Sarina Paesler,
Lei Wu,
...
M. Wanior,
H. TaipaleenmΓ€ki,
S. Bolamperti,
Z. Najafova,
K. Pantel,
C. Bokemeyer,
J. Qi,
E. Hesse,
S. Knapp,
S. Johnsen,
S. Loges
|
4 |
2018 |
4 π¦
|
π¦
|
CD45-mediated signals can trigger shedding of lymphocyte L-selectin.
M. Wroblewski,
A. Hamann
|
4 |
1997 |
4 π¦
|